SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 11 filers reported holding SINOVAC BIOTECH LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,507 | +50.7% | 6,879 | +50.7% | 0.00% | – |
| Q2 2023 | $29,542 | +9.4% | 4,566 | +10.3% | 0.00% | – |
| Q3 2022 | $27,000 | +3.8% | 4,141 | +5.1% | 0.00% | – |
| Q2 2022 | $26,000 | 0.0% | 3,941 | 0.0% | 0.00% | – |
| Q4 2021 | $26,000 | 0.0% | 3,941 | 0.0% | 0.00% | – |
| Q3 2021 | $26,000 | +4.0% | 3,941 | +2.6% | 0.00% | – |
| Q2 2021 | $25,000 | +56.2% | 3,841 | +53.6% | 0.00% | – |
| Q1 2021 | $16,000 | +60.0% | 2,500 | +66.7% | 0.00% | – |
| Q4 2020 | $10,000 | +11.1% | 1,500 | +7.1% | 0.00% | – |
| Q3 2020 | $9,000 | 0.0% | 1,400 | 0.0% | 0.00% | – |
| Q2 2020 | $9,000 | 0.0% | 1,400 | 0.0% | 0.00% | – |
| Q1 2020 | $9,000 | 0.0% | 1,400 | 0.0% | 0.00% | – |
| Q4 2019 | $9,000 | 0.0% | 1,400 | 0.0% | 0.00% | – |
| Q3 2019 | $9,000 | 0.0% | 1,400 | 0.0% | 0.00% | – |
| Q2 2019 | $9,000 | 0.0% | 1,400 | 0.0% | 0.00% | – |
| Q1 2019 | $9,000 | -85.0% | 1,400 | -83.6% | 0.00% | – |
| Q4 2018 | $60,000 | -9.1% | 8,552 | -2.4% | 0.00% | – |
| Q3 2018 | $66,000 | +15.8% | 8,758 | +14.0% | 0.00% | – |
| Q2 2018 | $57,000 | +185.0% | 7,684 | +237.0% | 0.00% | – |
| Q1 2018 | $20,000 | -89.4% | 2,280 | -90.4% | 0.00% | – |
| Q4 2017 | $188,000 | -95.9% | 23,851 | -96.3% | 0.00% | -100.0% |
| Q3 2017 | $4,581,000 | -32.3% | 649,848 | -35.2% | 0.00% | -50.0% |
| Q2 2017 | $6,770,000 | -78.3% | 1,003,039 | -81.6% | 0.00% | -60.0% |
| Q1 2017 | $31,194,000 | +81989.5% | 5,443,824 | +86309.9% | 0.01% | – |
| Q4 2016 | $38,000 | -86.9% | 6,300 | -87.2% | 0.00% | – |
| Q3 2016 | $291,000 | -2.3% | 49,293 | -1.9% | 0.00% | – |
| Q2 2016 | $298,000 | -11.6% | 50,272 | -4.7% | 0.00% | – |
| Q1 2016 | $337,000 | -19.2% | 52,772 | -27.6% | 0.00% | – |
| Q4 2015 | $417,000 | -61.4% | 72,862 | -65.8% | 0.00% | – |
| Q3 2015 | $1,081,000 | +207.1% | 213,016 | +218.3% | 0.00% | – |
| Q2 2015 | $352,000 | -27.9% | 66,921 | -32.1% | 0.00% | – |
| Q1 2015 | $488,000 | -20.0% | 98,573 | -15.5% | 0.00% | – |
| Q4 2014 | $610,000 | -28.5% | 116,679 | -34.2% | 0.00% | – |
| Q3 2014 | $853,000 | +83.0% | 177,301 | +114.7% | 0.00% | – |
| Q2 2014 | $466,000 | +121.9% | 82,562 | +182.0% | 0.00% | – |
| Q1 2014 | $210,000 | -47.0% | 29,274 | -54.7% | 0.00% | – |
| Q4 2013 | $396,000 | -58.0% | 64,607 | -59.0% | 0.00% | – |
| Q3 2013 | $942,000 | +96.2% | 157,419 | +28.9% | 0.00% | – |
| Q2 2013 | $480,000 | – | 122,126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,718,735 | $340,500,000 | 6.32% |
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.21% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.72% |
| Yorktown Management & Research Co Inc | 74,893 | $485,000 | 0.63% |
| Skandinaviska Enskilda Banken AB (publ) | 40,000 | $259,000 | 0.00% |
| Renaissance Technologies | 2,375,841 | $1,537,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,687 | $11,000 | 0.00% |
| NORTHERN TRUST CORP | 13,787 | $55,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 412 | $27,000 | 0.00% |